Two physicians offer commentaries about the use of prenatal predictive testing for a late-onset disease like Huntington's and question whether the pregnant woman should ultimately have the decisional autonomy to determine the quality of life of the unborn child.
Two physicians offer commentaries about the use of prenatal predictive testing for a late-onset disease like Huntington's and question whether the pregnant woman should ultimately have the decisional autonomy to determine the quality of life of the unborn child.
Chromosomal microarray analysis reveals many gene variants of unknown significance. The uncertainty about these variants—might they be deleterious or are they benign?—complicates genetic counseling.
Ruth M. Farrell, MD, MA, Holly Pederson, MD, and Shilpa Padia, MD
Though they claim to, direct-to-consumer genetic tests may not correctly identify an individual's ancestral background, and thus may overstate or understate one's risk for heritable disease.
Defenses of affirmative action rely on faulty assumptions about the educational value of student-body diversity and the best ways to address educational inequities.
To be best able to respond if third parties in assisted reproduction contracts break their terms, physicians should familiarize themselves with the contracts, encourage all parties to self-disclose, and, failing that, disclose material information to the other party.
This month, Virtual Mentor theme issue editor, Katie Falloon, a medical student at the Duke University School of Medicine, interviewed Dr. Thomas Price about the ethical and regulatory issues associated with assisted reproductive technologies (ART).